Dromelate Injection and Inotuzumab ozogamicin Intravenous
Determining the interaction of Dromelate Injection and Inotuzumab ozogamicin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dromelate Injection-Inova
- Dromelate Injection-Inova 4/1 topical
- Dromelate Injection-Inova 8/2 topical
- Dromelate Injection-Inova ACT
- Dromelate Injection-Inrebic
- Dromelate Injection-Inspra
- Inotuzumab ozogamicin Intravenous-Dronabinol
- Inotuzumab ozogamicin Intravenous-Dronabinol Capsules
- Inotuzumab ozogamicin Intravenous-Dronabinol Oral Solution
- Inotuzumab ozogamicin Intravenous-Dronedarone
- Inotuzumab ozogamicin Intravenous-Dronedarone Hydrochloride
- Inotuzumab ozogamicin Intravenous-Droperidol